BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31884139)

  • 1. Novel N,N-dimethylbarbituric-pyridinium derivatives as potent urease inhibitors: Synthesis, in vitro, and in silico studies.
    Biglar M; Mirzazadeh R; Asadi M; Sepehri S; Valizadeh Y; Sarrafi Y; Amanlou M; Larijani B; Mohammadi-Khanaposhtani M; Mahdavi M
    Bioorg Chem; 2020 Jan; 95():103529. PubMed ID: 31884139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-silico Designing, ADMET Analysis, Synthesis and Biological Evaluation of Novel Derivatives of Diosmin Against Urease Protein and Helicobacter pylori Bacterium.
    Kataria R; Khatkar A
    Curr Top Med Chem; 2019; 19(29):2658-2675. PubMed ID: 31724503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New 1,2,3-triazole-(thio)barbituric acid hybrids as urease inhibitors: Design, synthesis, in vitro urease inhibition, docking study, and molecular dynamic simulation.
    Asgari MS; Azizian H; Nazari Montazer M; Mohammadi-Khanaposhtani M; Asadi M; Sepehri S; Ranjbar PR; Rahimi R; Biglar M; Larijani B; Amanlou M; Mahdavi M
    Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000023. PubMed ID: 32596826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale virtual screening for the identification of new Helicobacter pylori urease inhibitor scaffolds.
    Azizian H; Nabati F; Sharifi A; Siavoshi F; Mahdavi M; Amanlou M
    J Mol Model; 2012 Jul; 18(7):2917-27. PubMed ID: 22139480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.
    Yang YS; Su MM; Zhang XP; Liu QX; He ZX; Xu C; Zhu HL
    Bioorg Med Chem Lett; 2018 Oct; 28(19):3182-3186. PubMed ID: 30170940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, In Silico Studies, and Evaluation of Syn and Anti Isomers of
    Kalatuwawege IP; Gunaratna MJ; Udukala DN
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and molecular docking study of piperazine derivatives as potent urease inhibitors.
    Taha M; Wadood A
    Bioorg Chem; 2018 Aug; 78():411-417. PubMed ID: 29689419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.
    Xiao ZP; Peng ZY; Dong JJ; Deng RC; Wang XD; Ouyang H; Yang P; He J; Wang YF; Zhu M; Peng XC; Peng WX; Zhu HL
    Eur J Med Chem; 2013 Oct; 68():212-21. PubMed ID: 23974021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitors.
    Pedrood K; Azizian H; Montazer MN; Mohammadi-Khanaposhtani M; Asgari MS; Asadi M; Bahadorikhalili S; Rastegar H; Larijani B; Amanlou M; Mahdavi M
    Sci Rep; 2021 May; 11(1):10607. PubMed ID: 34012008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and in silico studies of tetrahydropyrimidine analogs as urease enzyme inhibitors.
    Ahangarzadeh N; Shakour N; Rezvanpoor S; Bakherad H; Pakdel MH; Farhadi G; Sepehri S
    Arch Pharm (Weinheim); 2022 Oct; 355(10):e2200158. PubMed ID: 35833485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.
    Xiao ZP; Shi WK; Wang PF; Wei W; Zeng XT; Zhang JR; Zhu N; Peng M; Peng B; Lin XY; Ouyang H; Peng XC; Wang GC; Zhu HL
    Bioorg Med Chem; 2015 Aug; 23(15):4508-4513. PubMed ID: 26113187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-[(4'-Chlorophenyl) carbonyl-4-(aryl) thiosemicarbazide derivatives as potent urease inhibitors: Synthesis, in vitro and in silico studies.
    Ali B; Khan KM; Salar U; Kanwal ; Hussain S; Ashraf M; Riaz M; Wadood A; Taha M; Perveen S
    Bioorg Chem; 2018 Sep; 79():363-371. PubMed ID: 29859384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing sulphamethazine and sulphamethoxazole based Schiff bases as urease inhibitors; synthesis, characterization, molecular docking and ADME evaluation.
    Hamad A; Abbas Khan M; Ahmad I; Imran A; Khalil R; Al-Adhami T; Miraz Rahman K; Quratulain ; Zahra N; Shafiq Z
    Bioorg Chem; 2020 Dec; 105():104336. PubMed ID: 33096307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Structure-Activity Relationship Studies of N-monosubstituted Aroylthioureas as Urease Inhibitors.
    Ni WW; Fang HL; Ye YX; Li WY; Liu L; Fu ZJ; Dawalamu ; Zhu WY; Li K; Li F; Zou X; Ouyang H; Xiao ZP; Zhu HL
    Med Chem; 2021; 17(9):1046-1059. PubMed ID: 32819232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semicarbazone derivatives as urease inhibitors: Synthesis, biological evaluation, molecular docking studies and in-silico ADME evaluation.
    Qazi SU; Rahman SU; Awan AN; Al-Rashida M; Alharthy RD; Asari A; Hameed A; Iqbal J
    Bioorg Chem; 2018 Sep; 79():19-26. PubMed ID: 29709568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses, in vitro urease inhibitory activities of urea and thiourea derivatives of tryptamine, their molecular docking and cytotoxic studies.
    Kanwal ; Khan M; Arshia ; Khan KM; Parveen S; Shaikh M; Fatima N; Choudhary MI
    Bioorg Chem; 2019 Mar; 83():595-610. PubMed ID: 30513472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors.
    Mao WJ; Lv PC; Shi L; Li HQ; Zhu HL
    Bioorg Med Chem; 2009 Nov; 17(21):7531-6. PubMed ID: 19804978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoindolin-1-one derivatives as urease inhibitors: Design, synthesis, biological evaluation, molecular docking and in-silico ADME evaluation.
    Peytam F; Adib M; Mahernia S; Rahmanian-Jazi M; Jahani M; Masoudi B; Mahdavi M; Amanlou M
    Bioorg Chem; 2019 Jun; 87():1-11. PubMed ID: 30852231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, Antioxidant and In-Silico Studies of Potent Urease Inhibitors: N-(4-{[(4-Methoxyphenethyl)-(substituted)amino]sulfonyl}phenyl)acetamides.
    Abbasi MA; Raza H; Rehman AU; Siddiqui SZ; Nazir M; Mumtaz A; Shah SAA; Seo SY; Hassan M
    Drug Res (Stuttg); 2019 Feb; 69(2):111-120. PubMed ID: 30086567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological studies of the new cysteine-N-arylacetamide derivatives as a potent urease inhibitor.
    Montazer MN; Asadi M; Moradkhani F; Omrany ZB; Mahdavi M; Amanlou M
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):305-315. PubMed ID: 37436497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.